首页|微生态制剂对非酒精性脂肪性肝炎患者肠道菌群的影响研究

微生态制剂对非酒精性脂肪性肝炎患者肠道菌群的影响研究

扫码查看
目的 探究微生态制剂对非酒精性脂肪性肝炎患者肠道菌群的影响.方法 非随机选取2022年1月—2023年1月牡丹江医学院附属红旗医院收治的60例非酒精性脂肪性肝炎患者作为研究对象.按治疗方法分为干预组1、干预组2、干预组3和空白对照组,各15例.干预组1接受益生菌制剂干预,干预组2接受益生元制剂干预、干预组3接受益生菌制剂联合益生元制剂干预,4组均接受常规临床用药干预,干预时间均为3个月.对比4组患者肠道微生态变化和肝功能变化.结果 干预后,干预组3的肠杆菌属、肠球菌属、梭菌属计数均低于干预组1和干预组2,干预组1、干预组2低于空白对照组;干预组3的乳酸杆菌属、双歧杆菌属、拟杆菌属计数均高于干预组1和干预组2,干预组1、干预组2高于空白对照组,差异有统计学意义(P均<0.05).干预组1与干预组2的肠道微生态菌群计数比较,差异无统计学意义(P均>0.05).干预组3的肝功能指标水平均低于干预组1和干预组2,干预组1、干预组2低于空白对照组,差异有统计学意义(P均<0.05).干预组1与干预组2的肝功能指标水平比较,差异无统计学意义(P均>0.05).结论 微生态制剂对非酒精性脂肪性肝炎患者的肠道微生态和肝功能具有改善作用,且益生元制剂联合益生菌制剂对患者肠道微生态和肝功能的改善作用更好.
Effect of Microecology on Gut Microbiota in Patients with Non-alcoholic Steatohepatitis
Objective To investigate the effect of probiotics on the gut microbiota of patients with non-alcoholic ste-atohepatitis.Methods Sixty patients with non-alcoholic steatohepatitis admitted to Hongqi Hospital Affiliated to Mu-danjiang Medical College from January 2022 to January 2023 were non-randomly selected as the study subjects.They were divided into intervention group 1,intervention group 2,intervention group 3 and blank control group according to treatment methods,fifteen cases in each group.The intervention group 1 received probiotics intervention,the interven-tion group 2 received prebiotics intervention,and the intervention group 3 received probiotics combined with prebiot-ics intervention.All four groups received routine clinical medication intervention,and the intervention time was 3 months.The changes of intestinal microecology and liver function were compared among the four groups.Results Af-ter intervention,the counts of enterobacter,enterococcus and clostridium in intervention group 3 were lower than those in intervention group 1 and intervention group 2,and those in intervention group 1 and intervention group 2 were lower than those in blank control group;the counts of Lactobacillus,Bifidobacterium and Bacteroides in intervention group 3 were higher than those in intervention group 1 and intervention group 2,and those in intervention group 1 and intervention group 2 were higher than those in blank control group,and the difference was statistically significant(all P<0.05).There was no statistically significant difference between the intestinal microecological flora counts of inter-vention group 1 and intervention group 2(all P>0.05).The levels of liver function indexes in intervention group 3 were lower than those in intervention group 1 and intervention group 2,and those in intervention group 1 and intervention group 2 were lower than those in blank control group,and the difference was statistically significant(all P<0.05).There was no statistically significant difference in the levels of liver function indicators between intervention group 1 and intervention group 2(all P>0.05).Conclusion Probiotics can improve the intestinal microecology and liver func-tion of patients with nonalcoholic steatohepatitis,and probiotics combined with probiotics can improve the intestinal microecology and liver function of patients better.

Non-alcoholic steatohepatitisIntestinal floraMicroecologyLiver function

张晓东、鞠传余、黄晶晶、王惠琦、何花

展开 >

牡丹江医学院附属红旗医院感染性疾病科,黑龙江 牡丹江 157011

非酒精性脂肪性肝炎 肠道菌群 微生态制剂 肝功能

黑龙江省卫生健康委科研课题

20210303080286

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(17)
  • 13